Cargando…
CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals
Autor principal: | Merchant, Hamid A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988638/ https://www.ncbi.nlm.nih.gov/pubmed/33761987 http://dx.doi.org/10.1186/s40545-021-00315-w |
Ejemplares similares
-
EMA issues recommendations on impurities in medicines
Publicado: (2020) -
EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties
por: Dickson, Rumona, et al.
Publicado: (2018) -
Vaccins : les conseils d’EMA et d’ECDC
por: Dalmat, Yann-Mickael
Publicado: (2021) -
A Warning against the Negligent Use of Cannabidiol in Professional and Amateur Athletes
por: Lachenmeier, Dirk W., et al.
Publicado: (2019) -
Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA)
por: Shivji, Ragini, et al.
Publicado: (2022)